Abstract

Dual targeting of Toll-like receptor 4 and angiotensin-converting enzyme 2: aproposed approach to SARS-CoV-2 treatment.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call